LINC01503

ncRNA information

ncRNA name

LINC01503

Specific or universal ncRNAs

Specific ncRNAs

Class

Long noncoding RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

GATA1

Downstream target

miR-766-5p/PD-L1

Cancer information

Cancer name

Ovarian Carcinoma

Cancer site

qRT-PCR,Western blot,Dual-luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Carboplatin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

GATA1-induced LINC01503 expedited CBP resistance in OCa cells via the miR-766-5p/PD-L1 axis

Tissue resource

normal human ovarian epithelial cell lines IOSE-80

human ovarian cancer cell lines SKOV-3

human ovarian cancer cell lines OVCAR-10

human ovarian cancer cell lines CAOV-3

human ovarian cancer cell lines OVCAR-3

Experiment

None


Institute

BeNa Culture Collection

Country

China

Continent

Asia